Notable Analyst Rating Changes 1/19: EVVV, CIEN, JDSU, X Upgraded; IMAX, PAET, JASO, AKS Downgraded Jan 19, 2010 10:37AM
Biogen (BIIB) Must Raise Offer for Facet (FACT) to At Least $22/Share -Merriman Dec 16, 2009 01:19PM
Merriman Curhan Pounds The Table On Facet Biotechnology (FACT) After Board Formally Rejects Biogen Offer Oct 1, 2009 01:34PM
Notable Analyst Rating Changes 7/14: BK, UL, VMW, CNK, NILE Upgraded; MNKD, MAS, BKC, VOD Downgraded Jul 14, 2009 09:49AM